• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

BD surpasses 2 billion orders for COVID-19 vaccine injection devices

June 8, 2021 By Sean Whooley

BD_2B_vaccination_devices
[Image from BD]
BD (NYSE:BDX) announced today that orders for its needles and syringes hit 2 billion amid global COVID-19 vaccination efforts.

Franklin Lakes, N.J.-based BD’s latest milestone comes less than six months after the company surpassed 1 million orders for vaccine delivery devices.

The order total encompasses commitments to governments all over the globe, including the U.S., Australia, Brazil, Canada, France, Germany, India, the Philippines, Saudi Arabia, South Africa, Spain and the UK, among others.

In total, BD is supporting pandemic orders for more than 40 countries, non-governmental organizations and other partners, according to a news release. The company has delivered more than 900 million of the ordered injection devices to date, with the remainder to be delivered between now and the end of 2022.

Devices have been shipped to governments or appointed distribution partners, which will then distribute them to healthcare facilities based on each country’s individual distribution and allocation strategy, BD said, with discussions ongoing to ensure the supply of the delivery devices in late 2022 and beyond.

In December, BD announced its plan to invest $1.2 billion over four years to expand and upgrade multiple drug-delivery facilities. The company said at the time that it intended to open the new facility and build upon its six existing sites in Columbus, Nebraska; Cuautitlán, Mexico; Fukushima, Japan; Le Pont-de-Claix, France; Swindon, United Kingdom; and Tatabánya, Hungary.

Last month, the company confirmed its plans to build a $200 million production site for manufacturing COVID-19 vaccine injection devices in Zaragoza, Spain, which it expects to create up to 600 jobs by 2030.

“Expanding vaccination efforts are bringing restored hope and a long-awaited return to normalcy in multiple countries around the world,” BD president of medication delivery solutions Rick Byrd said in the release. “We are committed to continuing to support government partners and non-governmental organizations in these efforts to ensure health care providers on the front lines of this crisis have these much-needed injection devices to protect their patients from COVID-19.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: BD, coronavirus, COVID-19, COVID-19 vaccine

IN CASE YOU MISSED IT

  • Lyra Therapeutics appoints new chief medical officer
  • FDA lifts hold on Vertex’s insulin-producing cell therapy for diabetes
  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS